Neutrophil to lymphocyte ratio as a prognostic marker for advanced stage ovarian cancer

Irina Balescu; Nicolae Bacalbasa; Mihaela Vilcu; Claudia Stoica; Tarig Massawi; Sorin Petrea; Cristina Martac; Adriana Ciuvica; Andrei Voichitoiu; Victor Cauni; Bogdan Gaspar; Iulian Brezean

doi:10.37897/RMJ.2023.3.4

Romanian Medical Journal (Sep 2023)

Neutrophil to lymphocyte ratio as a prognostic marker for advanced stage ovarian cancer

Irina Balescu,
Nicolae Bacalbasa,
Mihaela Vilcu,
Claudia Stoica,
Tarig Massawi,
Sorin Petrea,
Cristina Martac,
Adriana Ciuvica,
Andrei Voichitoiu,
Victor Cauni,
Bogdan Gaspar,
Iulian Brezean

Affiliations

Irina Balescu: “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
Nicolae Bacalbasa: Department of Surgery, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania; “Dan Setlacec” Center of Visceral Surgery and Liver Transplantation, Fundeni Clinical Institute, Bucharest, Romania; Center of Excellence in Translational Medicine, Fundeni Clinical Institute, Bucharest, Romania
Mihaela Vilcu: Department of Surgery, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania; Department of Surgery, “Ion Cantacuzino” Clinical Hospital, Bucharest, Romania
Claudia Stoica: Department of Anatomy, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania; Department of Surgery, Ilfov County Emergency Hospital, Bucharest, Romania
Tarig Massawi: Department of Obstetrics and Gynecology, Ilfov County Emergency Hospital, Bucharest, Romania
Sorin Petrea: Department of Surgery, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania; Department of Surgery, “Ion Cantacuzino” Clinical Hospital, Bucharest, Romania
Cristina Martac: Department of Anesthesiology, Fundeni Clinical Institute, Bucharest, Romania
Adriana Ciuvica: Department of Obstetrics and Gynecology, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania; Department of Obstetrics and Gynecology, “Alessandrescu-Rusescu” National Institute of Mother and Child Care, Bucharest, Romania
Andrei Voichitoiu: Department of Obstetrics and Gynecology, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania; Department of Obstetrics and Gynecology, “Alessandrescu-Rusescu” National Institute of Mother and Child Care, Bucharest, Romania
Victor Cauni: Department of Urology, Colentina Clinical Hospital, Bucharest, Romania
Bogdan Gaspar: Department of Surgery, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania; Department of Visceral Surgery, Floreasca Clinical Emergency Hospital, Bucharest, Romania
Iulian Brezean: Department of Surgery, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania; Department of Surgery, “Ion Cantacuzino” Clinical Hospital, Bucharest, Romania

DOI: https://doi.org/10.37897/RMJ.2023.3.4
Journal volume & issue: Vol. 70, no. 3
pp. 133 – 136

Abstract

Read online

Ovarian cancer remains one of the most aggressive malignancies which is frequently diagnosed in advanced stages of the disease, when disseminated lesions are already present. In order to maximize the rates of complete debulking surgery, different prognostic markers have been investigated. The aim of the current paper is to investigate the prognostic value of neutrophil to lymphocyte ratio in advanced stage ovarian cancer patients submitted to debulking surgery.

Published in Romanian Medical Journal

ISSN: 1220-5478 (Print); 2069-606X (Online)
Publisher: Amaltea Medical Publishing House
Country of publisher: Romania
LCC subjects: Medicine: Medicine (General); Medicine: Surgery
Website: https://rmj.com.ro/

About the journal

Abstract

Keywords